DVA Stock Recent News

Warren Buffett, the longtime head of Berkshire Hathaway (BRK.A 0.99%) (BRK.B 0.95%), has delivered an impressive nearly 20% annualized return for shareholders since 1965, doubling the S&P 500's benchmark return. These exceptional results stem from Buffett and his late partner Charlie Munger's business acumen, combined with Berkshire's ability to strategically invest funds generated by its insurance business.

Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces significant risks from debt servicing costs, macroeconomic factors, and potential policy changes. The company's recent financial performance, including a decline in net income and increased debt costs, underscores my conservative valuation approach.

DENVER , Oct. 17, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced Jessica (Jess) Hergenreter as its new chief people officer (CPO). In this position, Hergenreter will oversee DaVita's People Services team, leading initiatives to engage and uplift DaVita's more than 70,000 teammates (employees) worldwide.

In the most recent trading session, DaVita HealthCare (DVA) closed at $164.82, indicating a +0.15% shift from the previous trading day.

TAMPA, Fla. , Oct. 11, 2024 /PRNewswire/ -- Following the widespread impact of Hurricane Milton, DaVita Kidney Care  dialysis centers have opened their doors to anyone in Florida needing treatment, including those who normally treat at other providers.

DVA's strong performance and growth strategies, including patient-centric care and international expansion, position it well for continued success despite potential risks.

TAMPA , Oct. 8, 2024  /PRNewswire/ -- DaVita Kidney Care , a leading provider of kidney care services, has activated its emergency response plan in preparation for Hurricane Milton's landfall in Florida. DaVita's emergency response plans focus on proactively dialyzing thousands of patients ahead of the storm in more than 150 centers.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

DaVita HealthCare (DVA) closed the most recent trading day at $163.08, moving +0.51% from the previous trading session.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.